TIMP1 and glioma: Immunohistochemical validation via the Human Protein Atlas confirmed elevated TIMP1 protein levels in CRC, breast cancer, glioma, hepatocellular carcinoma, and gastric adenocarcinoma (Figure 7C), underscoring its pan-cancer relevance.